Sleep medicineHumansSleep Initiation and Maintenance DisordersDouble-Blind MethodFemaleMale
A phase 3, multicenter, double-blind, randomized, placebo-controlled clinical trial of lemborexant in adults with insomnia disorder.
Wei-Feng Mi, Dan Wen, Lijun Xu, Jiyang Pan, Ping Gu, Changhong Wang, Jiyou Tang, Li Zhang, Chun-Feng Liu, Chengmei Yuan, Hanqiao Wang, Naoto Yamakawa, Takao Takase, Margaret Moline, Lin Lu
Published: 202610.1016/j.sleep.2025.108722
Abstract
INTRODUCTION: This study evaluated the efficacy and safety of lemborexant (LEM), a dual orexin-receptor antagonist, in participants with insomnia disorder in China. METHODS: E2006-J086-311 (Study 311; NCT04549168), a 1-month, multicenter, randomized,…
Preview only. Read the full abstract at the source